Very interesting, another exon skip drug with safety issues. Perhaps one of those execs can raise decent capital for us.
im not sure about what the fda exactly look for, but as James has said theyve approved drugs on less data than that which we will present. The word definitive is key and lose... im guessing nice differences from placebo to those dosed. Stopping decline / above zero from baseline would be a first ever in dmd outcomes.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 1.0¢ | $1.551K | 155.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3574230 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 3082000 | 3 |
View Market Depth
| Last trade - 11.22am 18/06/2025 (20 minute delay) ? |
| PER (ASX) Chart |